125288-06-4

Basic information

• Product Name: 4,6-di-O-benzyl-myo-inositol 2-dibenzylphosphate
• CAS NO: 125288-06-4
• Molecular Weight: 630.631
• Mol File: 125288-06-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4,6-di-O-benzyl-myo-inositol 2-dibenzylphosphate(CAS DataBase Reference)
• NIST Chemistry Reference: 4,6-di-O-benzyl-myo-inositol 2-dibenzylphosphate(125288-06-4)
• EPA Substance Registry System: 4,6-di-O-benzyl-myo-inositol 2-dibenzylphosphate(125288-06-4)

Safety Data

• Hazardous Substances Data: 125288-06-4(Hazardous Substances Data)

Upstream product

• 990-91-0 dibenzyl [[bis(benzyloxy)phosphoryl]oxy]phosphonate 
• 98510-25-9 meso-4,6-di-O-benzyl-D-myo-inositol-1,3,5-O-orthoformate 
• 98510-20-4 myo-Inositol orthoformate 
• 120268-33-9 4/6-O-benzyl-myo-inositol 1,3,5-monoorthoformate 
• 100-39-0 benzyl bromide 

Downstream Products

• 573-35-3 myo-Inositol 2-phosphate 

Relevant articles and documents

Phosphoric acid phaseomannite class compound and its preparation method and application (by machine translation)

The invention discloses a phaseomannite class phosphate compound, phosphoric acid phaseomannite class compound preparation method, and these phosphoric acid phaseomannite class compounds in the preparation of an anti-tumor drug. The use of non-small cell lung cancer cells to the compounds of this invention to inhibit the growth of tumor cells in active testing, that the compounds of this invention have high inhibition of tumor cell growth activity, some of the compound inhibiting activity even with cisplatin active quite, which indicates that the compounds of this invention have good cell penetrability and phosphorus esterase stability, can be used for the development of anti-tumor medicament. (by machine translation)